404 related articles for article (PubMed ID: 31233143)
41. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
[TBL] [Abstract][Full Text] [Related]
42. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
van Zelst JCM; Mus RDM; Woldringh G; Rutten MJCM; Bult P; Vreemann S; de Jong M; Karssemeijer N; Hoogerbrugge N; Mann RM
Radiology; 2017 Nov; 285(2):376-388. PubMed ID: 28609204
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.
Lehman CD; Wellman RD; Buist DS; Kerlikowske K; Tosteson AN; Miglioretti DL;
JAMA Intern Med; 2015 Nov; 175(11):1828-37. PubMed ID: 26414882
[TBL] [Abstract][Full Text] [Related]
44. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
[TBL] [Abstract][Full Text] [Related]
45. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Sardanelli F; Podo F; Santoro F; Manoukian S; Bergonzi S; Trecate G; Vergnaghi D; Federico M; Cortesi L; Corcione S; Morassut S; Di Maggio C; Cilotti A; Martincich L; Calabrese M; Zuiani C; Preda L; Bonanni B; Carbonaro LA; Contegiacomo A; Panizza P; Di Cesare E; Savarese A; Crecco M; Turchetti D; Tonutti M; Belli P; Maschio AD;
Invest Radiol; 2011 Feb; 46(2):94-105. PubMed ID: 21139507
[TBL] [Abstract][Full Text] [Related]
46. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
Bakker MF; de Lange SV; Pijnappel RM; Mann RM; Peeters PHM; Monninkhof EM; Emaus MJ; Loo CE; Bisschops RHC; Lobbes MBI; de Jong MDF; Duvivier KM; Veltman J; Karssemeijer N; de Koning HJ; van Diest PJ; Mali WPTM; van den Bosch MAAJ; Veldhuis WB; van Gils CH;
N Engl J Med; 2019 Nov; 381(22):2091-2102. PubMed ID: 31774954
[TBL] [Abstract][Full Text] [Related]
47. Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy.
Freitas V; Scaranelo A; Menezes R; Kulkarni S; Hodgson D; Crystal P
Cancer; 2013 Feb; 119(3):495-503. PubMed ID: 22952042
[TBL] [Abstract][Full Text] [Related]
48. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
[TBL] [Abstract][Full Text] [Related]
49. Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer.
An YY; Kim SH; Kang BJ; Suh YJ; Jeon YW
PLoS One; 2020; 15(3):e0230347. PubMed ID: 32163500
[TBL] [Abstract][Full Text] [Related]
50. Digital breast tomosynthesis plus mammography, magnetic resonance imaging plus mammography and mammography alone: A comparison of diagnostic performance in symptomatic women.
Tang W; Hu FX; Zhu H; Wang QF; Gu YJ; Peng WJ
Clin Hemorheol Microcirc; 2017; 66(2):105-116. PubMed ID: 28211806
[TBL] [Abstract][Full Text] [Related]
51. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
[TBL] [Abstract][Full Text] [Related]
52. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
Stoutjesdijk MJ; Boetes C; Jager GJ; Beex L; Bult P; Hendriks JH; Laheij RJ; Massuger L; van Die LE; Wobbes T; Barentsz JO
J Natl Cancer Inst; 2001 Jul; 93(14):1095-102. PubMed ID: 11459871
[TBL] [Abstract][Full Text] [Related]
53. Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.
Sankatsing VDV; Fracheboud J; de Munck L; Broeders MJM; van Ravesteyn NT; Heijnsdijk EAM; Verbeek ALM; Otten JDM; Pijnappel RM; Siesling S; de Koning HJ;
BMC Cancer; 2018 Mar; 18(1):256. PubMed ID: 29506487
[TBL] [Abstract][Full Text] [Related]
54. Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.
Pattacini P; Nitrosi A; Giorgi Rossi P; Iotti V; Ginocchi V; Ravaioli S; Vacondio R; Braglia L; Cavuto S; Campari C;
Radiology; 2018 Aug; 288(2):375-385. PubMed ID: 29869961
[TBL] [Abstract][Full Text] [Related]
55. Abnormal screens among nonmutation carriers in the High Risk Ontario Breast Screening Program.
Castelo M; Brown Z; Schellenberg AE; Mills JK; Eisen A; Muradali D; Grunfeld E; Scheer AS
Breast J; 2021 May; 27(5):423-431. PubMed ID: 33550650
[TBL] [Abstract][Full Text] [Related]
56. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
57. MRI breast screening in high-risk women: cancer detection and survival analysis.
Evans DG; Kesavan N; Lim Y; Gadde S; Hurley E; Massat NJ; Maxwell AJ; Ingham S; Eeles R; Leach MO; ; Howell A; Duffy SW
Breast Cancer Res Treat; 2014 Jun; 145(3):663-72. PubMed ID: 24687378
[TBL] [Abstract][Full Text] [Related]
58. The frequency of missed breast cancers in women participating in a high-risk MRI screening program.
Vreemann S; Gubern-Merida A; Lardenoije S; Bult P; Karssemeijer N; Pinker K; Mann RM
Breast Cancer Res Treat; 2018 Jun; 169(2):323-331. PubMed ID: 29383629
[TBL] [Abstract][Full Text] [Related]
59. Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
Passaperuma K; Warner E; Causer PA; Hill KA; Messner S; Wong JW; Jong RA; Wright FC; Yaffe MJ; Ramsay EA; Balasingham S; Verity L; Eisen A; Curpen B; Shumak R; Plewes DB; Narod SA
Br J Cancer; 2012 Jun; 107(1):24-30. PubMed ID: 22588560
[TBL] [Abstract][Full Text] [Related]
60. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
